Literature DB >> 17651741

Determinants of endothelial function in asymptomatic subjects with and without the metabolic syndrome.

Narbeh Melikian1, Philip Chowienczyk, Philip A MacCarthy, Ian L Williams, Stephen B Wheatcroft, Roy Sherwood, Christopher Gale, Ajay M Shah, Mark T Kearney.   

Abstract

We investigated the determinants of endothelial function in 100 asymptomatic, non-diabetic, non-smokers with and without the metabolic syndrome ((MS)--defined by ATP-III criteria). Subjects with MS (n=24) had greater endothelial dysfunction (ED, P<0.001) than subjects without MS. One-way analysis of variance demonstrated a significant negative linear trend between level of ED (F=21.89; P<0.001) and number of ATP-III metabolic diagnostic criteria present in each subject. In a stepwise multivariate logistic regression model presence/absence of MS was the only independent determinant of ED (P=0.01). Age, gender, LDL cholesterol, C-reactive protein, interleukin-6 and tumour necrosis factor-alpha receptor 2 had no independent influence on endothelial function. In the absence of MS as variable there was no independent association between the remaining variables and endothelial function. Receiver operating characteristic (ROC) curves demonstrated that a combination of age, LDL cholesterol and CRP levels and presence/absence of MS can be used to predict ED (area under curve 0.81+/-0.06) and thus potentially may be used as a simple screening test to identify subjects with the greatest level of ED (sensitivity=0.82, specificity=0.72). Our study demonstrated that subjects with MS had greater ED. The extent of ED increased with presence of each additional ATP-III diagnostic criteria. Presence/absence of MS was the only independent predictor of ED and in conjunction with age, LDL cholesterol and CRP levels could be used as a potential simple clinical screening test for ED.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17651741     DOI: 10.1016/j.atherosclerosis.2007.06.009

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  8 in total

1.  NT-proBNP, race and endothelial function in the Multi-Ethnic Study of Atherosclerosis.

Authors:  Sushan Yang; Shi Huang; Lori B Daniels; Joseph Yeboah; Joao A C Lima; Valentina Cannone; John C Burnett; Joshua A Beckman; J Jeffrey Carr; Thomas J Wang; Deepak K Gupta
Journal:  Heart       Date:  2019-05-31       Impact factor: 5.994

2.  C-reactive protein concentration as a significant correlate for metabolic syndrome: a Chinese population-based study.

Authors:  Tsan Yang; Chi-Hong Chu; Po-Chien Hsieh; Chih-Hsung Hsu; Yu-Ching Chou; Shih-Hsien Yang; Chyi-Huey Bai; San-Lin You; Lee-Ching Hwang; Tieh-Chi Chung; Chien-An Sun
Journal:  Endocrine       Date:  2012-07-19       Impact factor: 3.633

3.  Insulin resistance impairs circulating angiogenic progenitor cell function and delays endothelial regeneration.

Authors:  Matthew B Kahn; Nadira Y Yuldasheva; Richard M Cubbon; Jessica Smith; Sheikh T Rashid; Hema Viswambharan; Helen Imrie; Afroze Abbas; Adil Rajwani; Amir Aziz; Vivek Baliga; Piruthivi Sukumar; Matthew Gage; Mark T Kearney; Stephen B Wheatcroft
Journal:  Diabetes       Date:  2011-02-11       Impact factor: 9.461

Review 4.  Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome.

Authors:  Sridevi Devaraj; Simona Valleggi; David Siegel; Ishwarlal Jialal
Journal:  Curr Atheroscler Rep       Date:  2010-03       Impact factor: 5.113

Review 5.  The IGF-1 receptor and regulation of nitric oxide bioavailability and insulin signalling in the endothelium.

Authors:  V Kate Gatenby; Helen Imrie; Mark Kearney
Journal:  Pflugers Arch       Date:  2013-01-22       Impact factor: 3.657

Review 6.  Human C-reactive protein and the metabolic syndrome.

Authors:  Sridevi Devaraj; Uma Singh; Ishwarlal Jialal
Journal:  Curr Opin Lipidol       Date:  2009-06       Impact factor: 4.776

7.  Vascular function measured by fingertip thermal reactivity is impaired in patients with metabolic syndrome and diabetes mellitus.

Authors:  Naser Ahmadi; Fereshteh Hajsadeghi; Khawar Gul; Michael Leibfried; Daniel DeMoss; Robert Lee; Ferdinand Flores; Khurram Nasir; Harvey Hecht; Morteza Naghavi; Matthew J Budoff
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-11       Impact factor: 3.738

8.  Metabolic syndrome in the pediatric population: a short overview.

Authors:  Natasa Marcun Varda; Alojz Gregoric
Journal:  Pediatr Rep       Date:  2009-06-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.